# Proteases in Patients With Prostate Cancer That Has Spread to the Bone

> **NCT00899665** · — · COMPLETED · sponsor: **Barbara Ann Karmanos Cancer Institute** · enrollment: 31 (actual)

## Conditions studied

- Anemia
- Metastatic Cancer
- Myelodysplastic Syndromes
- Precancerous Condition
- Prostate Cancer

## Interventions

- **GENETIC:** fluorescence in situ hybridization
- **GENETIC:** microarray analysis
- **GENETIC:** molecular diagnostic method
- **OTHER:** immunohistochemistry staining method
- **OTHER:** laboratory biomarker analysis
- **PROCEDURE:** biopsy
- **PROCEDURE:** immunoscintigraphy

## Key facts

- **NCT ID:** NCT00899665
- **Lead sponsor:** Barbara Ann Karmanos Cancer Institute
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2001-07
- **Primary completion:** 2006-09
- **Final completion:** 2008-01
- **Target enrollment:** 31 (ACTUAL)
- **Last updated:** 2014-02-11

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00899665

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00899665, "Proteases in Patients With Prostate Cancer That Has Spread to the Bone". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT00899665. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*